"Angioedemas, Hereditary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inherited disorders that are characterized by subcutaneous and submucosal EDEMA in the upper RESPIRATORY TRACT and GASTROINTESTINAL TRACT.
| Descriptor ID |
D054179
|
| MeSH Number(s) |
C14.907.079.500 C16.320.078 C17.800.862.945.066.500 C20.543.480.904.066.500
|
| Concept/Terms |
Angioedemas, Hereditary- Angioedemas, Hereditary
- Angioneurotic Edema, Hereditary
- Angioneurotic Edemas, Hereditary
- Edema, Hereditary Angioneurotic
- Edemas, Hereditary Angioneurotic
- Hereditary Angioneurotic Edemas
- C1 Inhibitor Deficiency
- Hereditary Angioedemas
- Hereditary Angioneurotic Edema
- C1 Esterase Inhibitor Deficiency
- Angioedema, Hereditary
- Hereditary Angioedema
|
Below are MeSH descriptors whose meaning is more general than "Angioedemas, Hereditary".
Below are MeSH descriptors whose meaning is more specific than "Angioedemas, Hereditary".
This graph shows the total number of publications written about "Angioedemas, Hereditary" by people in this website by year, and whether "Angioedemas, Hereditary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2010 | 4 | 0 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 2 | 4 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 2 | 4 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Angioedemas, Hereditary" by people in Profiles.
-
Bradykinin formation by mutant plasminogen. Blood. 2022 05 05; 139(18):2732-2733.
-
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy. 2022 07; 77(7):1961-1990.
-
Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. J Allergy Clin Immunol Pract. 2022 03; 10(3):716-722.
-
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema. Clin Rev Allergy Immunol. 2021 Jun; 60(3):348-356.
-
Hereditary angioedema: Investigational therapies and future research. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S51-S54.
-
sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. Mol Immunol. 2020 03; 119:27-34.
-
C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema. J Allergy Clin Immunol Pract. 2020 03; 8(3):892-900.
-
Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade. Immunol Allergy Clin North Am. 2017 08; 37(3):513-525.
-
Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema. J Allergy Clin Immunol. 2017 Jul; 140(1):170-176.
-
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent. Clin Rev Allergy Immunol. 2016 Oct; 51(2):207-15.